The Quantellect read.As of Nov 19, 2026, 11 active firms cover Pharvaris BV: 10 rate it Buy or better, 1 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. Targets range widely, $30.00 to $79.00 (about 2.6x), a sign of real disagreement on valuation. The average target of $55.36 sits 76% above the current $31.53. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 9 to 10 over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.79 next quarter toward $-2.69 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS11 active firms
Buy
Strong Buy00%
Buy1091%
Neutral19%
Sell00%
Strong Sell00%
Based on 11 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$55.36
+75.6% upside
Average target across 11 active firms as of Nov 19, 2026 vs $31.53 current
Highest Target$79.00
Average Target$55.36
Lowest Target$30.00
Detailed analyst forecasts for PHVS
Showing 1–13 of 13 named analysts shown · 11 active firms in the rating projection
As of Nov 19, 2026, 10 of 11 active firms rate PHVS a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
PHVS EPS & revenue forecast
EPS · NEXT QUARTER
$-0.79
Range $-0.96 – $-0.66 · 6 analysts
Next period, 6 analysts expect Pharvaris BV to earn $-0.79 a share (range $-0.96 – $-0.66), versus — a year earlier. Full-year consensus is $-2.64, growing to $-2.69 the year after.
REVENUE · NEXT QUARTER
$0
Range $0 – $0 · 6 analysts
Revenue is expected to reach $0 (range $0 – $0). Full-year consensus is $0, rising to $33.2M next year.
Top analysts covering Pharvaris BV
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on PHVS.
#1
Jonathan Wolleben
JMP Securities · Rank #54
Buy
$79.00+150.6% to target
Overall win rate
43%
+ Follow
#2
Laura Chico
Wedbush · Rank #55
Buy
$50.00+58.6% to target
Overall win rate
46%
+ Follow
#3
Joseph Schwartz
Leerink Partners · Rank #242
Buy
$65.00+106.2% to target
Overall win rate
36%
+ Follow
#4
Debjit Chattopadhyay
Guggenheim · Rank #248
Buy
$44.00+39.5% to target
Overall win rate
39%
+ Follow
#5
Patrick R. Trucchio
HC Wainwright & Co. · Rank #308
Buy
$60.00+90.3% to target
Overall win rate
36%
+ Follow
PHVS stock forecast FAQ
What is PHVS's average 12-month price target?+
The 11 active firms with a live target average $55.36 for Pharvaris BV over the next 12 months, ranging from a $79.00 high to a $30.00 low, as of Nov 19, 2026.
Is PHVS stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 11 active firms as of Nov 19, 2026, 10 rate it Buy or Strong Buy, 1 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for PHVS?+
The Street-high target is $79.00 (Citizens), and the Street-low is $30.00 (B of A Securities). The average of all 11 active-firm targets is $55.36.
How many active Wall Street firms cover PHVS?+
11 active firms have a recognized rating on Pharvaris BV as of Nov 19, 2026, and 11 active firms carry a live 12-month price target.
Who is the most accurate analyst covering PHVS?+
Among analysts who currently cover PHVS, Jonathan Wolleben of JMP Securities has the strongest overall Quantellect track record (Rank #54). Their current call is Buy with a $79.00 target.
What is Pharvaris BV's projected EPS for next quarter?+
The consensus estimate is $-0.79 per share (range $-0.96 – $-0.66) across 6 analysts. Full-year EPS is projected at $-2.64, rising to $-2.69 the following year.
How much revenue is Pharvaris BV expected to report next quarter?+
Consensus revenue is $0 (range $0 – $0). Full-year revenue is projected at $0, growing to $33.2M next year.
Have analysts been upgrading or downgrading PHVS lately?+
As of Nov 19, 2026, 10 of 11 active firms rate PHVS a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their PHVS calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.